Join Now

Category Archives: Industry News

University of Utah to Speed Process of Bringing New Therapeutics to Patients

By admin | Published November 20, 2020

University of Utah Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center: Nov 18, 2020 10:00 AM The university’s Huntsman Cancer Institute (HCI), College of Pharmacy, and the Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center have partnered to establish the University of Utah Therapeutics Accelerator Hub (U2TAH, or the Accelerator). Photo credit: University […]

Also posted in Policy News | | Leave a comment

Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance

By admin | Published November 6, 2020

Logan, UT, October 28, 2020 – Quansys Biosciences announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based IgG antibody test. A positive IgG antibody result identifies patients who have been exposed to the SARS-CoV-2 virus and, as part of their recovery, demonstrated an adaptive […]

| Leave a comment

Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal

By Denise Bell | Published October 30, 2020

Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement Medal for Science and Technology for his contribution in the field of biotechnology and pharmaceuticals. “This honor is well-deserved,” said Kelvyn Cullimore, president and CEO of BioUtah. “Dr. Patel has been instrumental in founding and bringing a […]

Also posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors 

By Denise Bell | Published October 14, 2020

CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced that the first patient has been dosed with TP-1454, an investigational small-molecule pyruvate kinase M2 isoform (PKM2) activator, administered alone and in combination with ipilimumab and nivolumab, in a Phase 1/1b study in patients with advanced […]

Also posted in BioUtah News, Life Sciences Industry News | | Leave a comment

Pediatric Rare Disease Voucher Program Extended

By Denise Bell | Published October 9, 2020

Congress recently provided a short-term extension until December 11 of the Rare Pediatric Disease Priority Review Voucher program. The program was set to expire on September 30, but was given a reprieve in the Continuing Appropriations Act, 2021 and Other Extensions Act (H.R. 8337) that kept the government funded. Congress will have to act again […]

Also posted in Federal News, Policy News | | Leave a comment

Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor

By Denise Bell | Published October 9, 2020

Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical device company that has developed the XenoscopeTM, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed to be fog proof, the Xenoscope minimizes common visualization challenges and provides consistent image quality through electrocautery smoke. MPVF’s […]

Also posted in BioUtah News, Funding, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Johnson & Johnson Signs Communiqué on Expanded Global Access for COVID-19

By Denise Bell | Published October 9, 2020

Johnson & Johnson recently announced that it’s joined 15 other companies in signing a Communiquie on Expanded Global Access to ensure that people everywhere – regardless of their income level – have access to COVID-19 vaccines, therapeutics and diagnostics under development at these companies.  Each of the signing companies—AstraZeneca; Bayer; bioMérieux; Boehringer Ingelheim; Bristol Myers […]

Also posted in COVID-19 Updates | | Leave a comment

Xenocor Granted Breakthrough Technology Agreement with Premier Inc.

By admin | Published October 9, 2020

Xenoscope New Disposable Fog-Free Laparoscopic System Made Available to 4,000 Healthcare Facilities in the USA SALT LAKE CITY, October 5, 2020–– Xenocor, Inc. offering the world’s first disposable articulating laparoscope, has received a group purchasing agreement with Premier Inc. for their single use Xenoscope™, in the surgical disposable scope category. The Xenocor disposable laparoscopic system […]

Also posted in Life Sciences Industry News | | Leave a comment

Mountain Pacific Venture Fund Invests in Laparoscopic Device Company Xenocor

By admin | Published October 9, 2020

For Immediate Release Xenocor’s single-use laparoscope, Xenoscope, increases access to minimally invasive surgical care Salt Lake City, October 5, 2020 – Mountain Pacific Venture Fund (MPVF) announced an investment in Xenocor, a Salt Lake City, Utah-based medical device company that has developed the Xenoscope™, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed […]

Also posted in Life Sciences Industry News | | Leave a comment

Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives

By Denise Bell | Published October 2, 2020

Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized by Utah Business Magazine as among Utah’s top C-Suite executives. In introducing the 2020 CXO of the Year honorees, the magazine notes that “now more than ever we need strong leaders to guide our businesses forward and […]

Also posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

J&J Enters Phase 3 Trial for COVID-19 Vaccine

By Denise Bell | Published September 25, 2020

BioUtah member Johnson & Johnson (J&J) announced that they’ve started the global phase 3 trial of Janssen’s single-dose vaccine candidate, following phase 1/2 studies that demonstrated safety and immunogenicity.  “As COVID-19 continues to impact the daily lives of people around the world, our goal remains the same – leveraging the global reach and scientific innovation […]

Also posted in BioUtah COVID-19 Analysis, Federal News | | Leave a comment

The Point Kick Off

By Denise Bell | Published September 18, 2020

On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning efforts to redevelop the site of the Utah State Prison (The Point) in Draper. Many of our industry leaders are participating on The Point’s Education, Research and Innovation working group – Randy Rasmussen (former BioFire CEO), Gary […]

Also posted in BioUtah News, State News, Utah's Life Sciences Companies | | Leave a comment

A Special Thanks To Our Elite Members